The gene codes for the protein E-cadherin (epithelial) Many subtypes of cadherins (= calcium-dependent adhesion) Deactivating mutations are pathogenic.

Slides:



Advertisements
Similar presentations
Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Advertisements

Genomics-Based Personalized Healthcare Presented by: Charis Eng, MD, PhD -Chair & Director -Genomic Medicine Institute -Director -Center for Personalized.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Prof. Faisal Ghani Siddiqui FCPS; PGDip-bioethics; MCPS-HPE
Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.
Princess Alexandra Hospitals NHS Trust Breast Unit Family History Clinic.
10 November 2011 Genetic counseling for breast cancer risk Aichu Huang, MS. CGC. Department of Medical Genetics National Taiwan University Hospital.
Martina Rastovac Mentor: A. Žmegač Horvat. Actor Patrick Swayze died after a 20-month battle with pancreatic cancer. He was 57.Patrick Swayze.
Hereditary Factors in Breast Cancer
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Introduction to Genetics, with a Focus on Human Genetics.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Journal club Dr Eyad Al-Saeed Radiation Oncology 8-Sep-2007.
Monogenic disorders risk calculations seminar No 425 Heredity.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
The Facts about Breast Cancer
Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR.
Breast Imaging Made Brief and Simple
Breast Cancer Shannan McQuade & Ashley Haman. History of Breast Cancer Ancient Egyptians discovered Breast Cancer –Over 3,500 years ago Hippocrates discovered.
Colorectal cancer Khayal AlKhayal MD,FRCSC
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
Lars Påhlman Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden How to handle peritoneal carcinomatosis found at laparotomy.
Breast Cancer By George Rezk.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Breast Cancer Hitham G. Falahi 4NU04. The most common cancer in females…
Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.
SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG
Nurse Navigators and the Cancer Institute Yousuf A. Gaffar, MD Hematology / Medical Oncology The Cancer Institute University of Maryland St. Joseph Medical.
Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Breast Cancer Methods for Early Detection. Breast Cancer What It Is Methods of Early Detection Risk Factors.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Arch Neurol. 2009;66(8): Published online June 8, 2009 (doi: /archneurol ).
Breast Cancer. What is this Disease? Second leading cause of cancer death in women Malignant (cancerous) tumor –Develops from cells in the breast that.
 General recommendations -adjuvant systemic therapy :with tamoxifen or multiple-chemotherapy agent :lower the incidence of recurrence by about 30% - in.
Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )
Understanding Your Breast Reconstruction Options: Pedicled Flaps Frederick J. Duffy, Jr. M.D., F.A.C.S. Clinical Assistant Professor UT-Southwestern Medical.
RPS ZU. Mrs. Liliane D…., 72 year-old No past medical history Mai 2011 – Loss of weight (4kg in 6 months) – Asthenia Thoraco-abdomino pelvic.
Breast Cancer By: Christen Scott.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
How will you approach the 35-year old, with a 2x2x2cm, firm, mobile, well-circumscribed non-tender mass on her R breast?
March 10, 2014 NURS 330 Human Reproductive Health.
 Among all cancers, breast cancer has been the 2 nd leading cause of death in women (right behind lung cancer)  Causes about 40,000 deaths annually.
Genetics: For this Generation and the Next
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Cancer Basics EQ: What does cancer have to do with the cell cycle?
Genetic predisposition to
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
HEAPHY 1 & 2 CASE RACE 1 – DIAG Yvonne CLARKE Sat 31 st Aug 2013 Session 3 / CR1-4 13:16 – 13:20 WELLINGTON ABSTRACT Following a woman’s pathway from her.
Breast Cancer »Breast cancer is a malignant tumor that starts in the cells of the breast. »The disease occurs almost entirely in women,but men can get.
부산대학교병원 김 주 연 2012 년 세포병리학회 가을학술대회 월례집담회.  F/52  Past history : 03’ left breast operation, on follow up  Lower abdominal pain (12’ April)  Physical.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Genetic Counseling Yahwardiah Siregar Sry Suryani W Mutiara Indah Sari.
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
Beaumont Hospital Breast Service
Indications for Breast MR Imaging
Diffuse Type Gastric and Lobular Breast Carcinoma in a Familial Gastric Cancer Patient with an E-Cadherin Germline Mutation  Gisela Keller, Holger Vogelsang,
Department of General Surgery, Upper Gastrointestinal Unit,
Family Grandfather Grandmother Mother Father Aunt Uncle Sister Brother
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status  Emma Z. Mi, BA, Ella Z. Mi, BA, Massimiliano.
Hereditary Diffuse Gastric Cancer: Diagnosis and Management
JOHN’S FAMILY.
Jason P. Wilson, MD, MBA, FACS Deena Wahba, MSc, CGC
Hereditary Diffuse Gastric Cancer: Diagnosis and Management
Biology of hereditary breast and ovarian cancer (HBOC)
Presentation transcript:

The gene codes for the protein E-cadherin (epithelial) Many subtypes of cadherins (= calcium-dependent adhesion) Deactivating mutations are pathogenic Loss of E-cadherin expression

J Med Genet 2015; 52: Consensus Conference 2014

 CDH 1 mutation positiv – total gastrectomy  D1 lymphnode resection (pos lympnodes in T1 a 2-6% in T1 b 17-25%)  Ensure proximal and distal margins to be without gastric mucosa  At age – (consider family phenotype)  Endoscopic surveillance not sufficient  Age > 75 - consider carefully

 Always before ”prophylactic” operation  When patients decline operation  In clinically defined HDGC families without CDH1 mutation  Multiple (30) biopsies (5 x 6 regioner) Purpose 1. Already invasive cancer ? 2. If a microscopic focus of SRCC is shown – motivation for surgery

 32 – year old man SRCC of the stomach Laparotomy (GEA): Carcinose + liver metastases Died few weeks postoperatively with unclear CNS symptoms (carcinomatosis o.p)  Father died of gastric cancer 42 years old  3 cousins of the father also had gastric cancer at an early age  A patogenic CDH – 1 mutation (2 – bp deletion in exon 5) was shown

42 † + 3 Cousins with gastric cancer 2 died young Do not want test † Probanden † Died of gastric cancer Do not want operation or control Prophylactic gastrectomy 5 siblings: 3 positive 1 negative 1 no test 2 operated 1 cousin : negative (married to the probands sister)

 44 year old man subtotal gastrectomy and chemotherapy for T2N2M0 SRCC. Metastases to neck lymphnodes 3 months later † 45 år  Grandfather died of gastric cancer  Mother died at 27 years with peritoneal carcinosis  Mothers brother and sister died of gastric SRCC – 51 and 68 years old  Brother died of gastric SRCC - 49 år CDH 1 mutation: c insTT i exon 10 Uncertain effect – testet and found to be pathogenic

††† †† † † : Prophylactic gastrectomy Proband 9 asymptomatic members testet positive : 5 total gastrectomy in DK 1 probably operated in Italy 1 had disseminated disease when testet (had refused the test a year earlier) 2 are 19 and 20 years. (one living in Sweden)

SRCC: Microscopic focus of Signet Ring Cell Carcinoma (T1A) Bardram L, Hansen TVO, Gerdes AM et al. Familial Cancer 2014; 13:

Kg Weightloss % at 1 year T3 cancer + chemo

The Impact of Prophylactic Total Gastrectomy on Health-Related Quality of Life: A Prospective Cohort Study. Worster, Elizabeth; Liu, Xinxue; Richardson, Susan; Hardwick, Richard; Dwerryhouse, Sarah; Caldas, Carlos; Fitzgerald, Rebecca Annals of Surgery. 260(1):87-93, July % weight loss Physical function scorePhysical health score

 Recommended at age  Consider familial ”phenotype”  Age > 75 - consider carefully  What about pregnancy  delivery of healthy child documented  artificial fertilization after egg sorting

 Was early pregnant when testet positive  Chose abortion - in order to proceed with gastrectomy immediately (grandmother died at age 27 of dessiminated cancer)  3 years later : Delivery of healthy child (mutation negative)  Had artificial fertilization after egg sorting  Prophylactic mastectomy a week ago (16 months after delivery)- 31 year old

 Lobular breast cancer  Annual MRI 3 women in family B: One had a small invasive cancer found by MRI – multiple LBC foci found in the resected specimen Had subsequent prophylactic bilateral mastectomy: Multiple foci of LBC Two had bilateral prophylactic mastectomy: No malignancies Whole specimen not examined for microscopic LBC foci Not sufficient evidence for recommending prophylactic mastectomy